Literature DB >> 29879746

Interobserver Agreement for Contrast-Enhanced Ultrasound (CEUS)-Based Standardized Algorithms for the Diagnosis of Hepatocellular Carcinoma in High-Risk Patients.

Barbara Schellhaas1, Lukas Pfeifer1, Christian Kielisch1, Ruediger Stephan Goertz1, Markus F Neurath1, Deike Strobel1.   

Abstract

OBJECTIVES: This pilot study aimed at assessing interobserver agreement with two contrast-enhanced ultrasound (CEUS) algorithms for the diagnosis of hepatocellular carcinoma (HCC) in high-risk patients.
METHODS: Focal liver lesions in 55 high-risk patients were assessed independently by three blinded observers with two standardized CEUS algorithms: ESCULAP (Erlanger Synopsis of Contrast-Enhanced Ultrasound for Liver Lesion Assessment in Patients at risk) and ACR-CEUS-LI-RADSv.2016 (American College of Radiology CEUS-Liver Imaging Reporting and Data System). Lesions were categorized according to size and ultrasound contrast enhancement in the arterial, portal-venous and late phase. Interobserver agreement for assessment of enhancement pattern and categorization was compared between both CEUS algorithms. Additionally, diagnostic accuracy for the definitive diagnosis of HCC was compared. Histology and/or CE-MRI and follow-up served as reference standards.
RESULTS: 55 patients were included in the study (male/female, 44/ 11; mean age: 65.9 years). 90.9 % had cirrhosis. Histological findings were available in 39/55 lesions (70.9 %). Reference standard of the 55 lesions revealed 48 HCCs, 2 intrahepatic cholangiocellular carcinomas (ICCs), and 5 non-HCC-non-ICC lesions. Interobserver agreement was moderate to substantial for arterial phase hyperenhancement (ĸ = 0.53 - 0.67), and fair to moderate for contrast washout in the portal-venous or late phase (ĸ = 0.33 - 0.53). Concerning the CEUS-based algorithms, the interreader agreement was substantial for the ESCULAP category (ĸ = 0.64 - 0.68) and fair for the CEUS-LI-RADS® category (ĸ = 0.3 - 0.39). Disagreement between observers was mostly due to different perception of washout.
CONCLUSION: Interobserver agreement is better for ESCULAP than for CEUS-LI-RADS®. This is mostly due to the fact that perception of contrast washout varies between different observers. However, interobserver agreement is good for arterial phase hyperenhancement, which is the key diagnostic feature for the diagnosis of HCC with CEUS in the cirrhotic liver. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29879746     DOI: 10.1055/a-0612-7887

Source DB:  PubMed          Journal:  Ultraschall Med        ISSN: 0172-4614            Impact factor:   6.548


  6 in total

1.  Inter-reader reliability of contrast-enhanced ultrasound Liver Imaging Reporting and Data System: a meta-analysis.

Authors:  Ji Hun Kang; Sang Hyun Choi; Ji Sung Lee; Dong Wook Kim; Jong Keon Jang
Journal:  Abdom Radiol (NY)       Date:  2021-06-22

Review 2.  Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients.

Authors:  Victoria Chernyak; Kathryn J Fowler; Aya Kamaya; Ania Z Kielar; Khaled M Elsayes; Mustafa R Bashir; Yuko Kono; Richard K Do; Donald G Mitchell; Amit G Singal; An Tang; Claude B Sirlin
Journal:  Radiology       Date:  2018-09-25       Impact factor: 11.105

Review 3.  Update in Contrast-Enhanced Ultrasound.

Authors:  Steffen Beckmann; Jörg H Simanowski
Journal:  Visc Med       Date:  2020-11-26

4.  Interobserver agreement for contrast-enhanced ultrasound of liver imaging reporting and data system: A systematic review and meta-analysis.

Authors:  Jun Li; Ming Chen; Zi-Jing Wang; Shu-Gang Li; Meng Jiang; Long Shi; Chun-Li Cao; Tian Sang; Xin-Wu Cui; Christoph F Dietrich
Journal:  World J Clin Cases       Date:  2020-11-26       Impact factor: 1.337

5.  Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis.

Authors:  Gianpaolo Vidili; Marco Arru; Giuliana Solinas; Diego Francesco Calvisi; Pierluigi Meloni; Assunta Sauchella; Davide Turilli; Claudio Fabio; Antonio Cossu; Giordano Madeddu; Sergio Babudieri; Maria Assunta Zocco; Giovanni Iannetti; Enza Di Lembo; Alessandro Palmerio Delitala; Roberto Manetti
Journal:  World J Gastroenterol       Date:  2022-07-21       Impact factor: 5.374

6.  Real-life assessment of standardized contrast-enhanced ultrasound (CEUS) and CEUS algorithms (CEUS LI-RADS®/ESCULAP) in hepatic nodules in cirrhotic patients-a prospective multicenter study.

Authors:  D Strobel; E-M Jung; M Ziesch; M Praktiknjo; A Link; C F Dietrich; C Klinger; M Schultheiß; D Jesper; B Schellhaas
Journal:  Eur Radiol       Date:  2021-04-15       Impact factor: 5.315

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.